Teva to acquire Mexico's Rimsa for $2.3 billion - MarketWatch
Israel stocks rise, led by Teva, ICL - MarketWatch
Teva Pharmaceuticals (@TevaUSA) / Twitter
Teva Stock Is Falling as an Analyst Says It Needs 'Numerous Litigation Wins' | Barron's
Teva earnings preview: Opioid suits are 'key' - MarketWatch
Is the new Teva x Ugg collection fashion-forward or just plain ugly? - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Prosecutors Sue Teva's U.S. Business Over Charitable Donations - WSJ
TEVA -- Is Its Stock Price A Worthy Investment? Learn More.
Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Announces Abstracts at the ACAAI Annual Scientific Meeting
Teva stock drops on guidance, manufacturing problems - MarketWatch
Drug maker Teva's U.S. unit indicted on price-fixing charges - MarketWatch
Teva shares surge on corporate shake-up - MarketWatch
Teva Pharmaceuticals reports earnings on Wednesday. Here's what to expect - MarketWatch
Teva Pharmaceutical Names Richard Francis as CEO, President - WSJ
Teva Pharmaceuticals - Wikipedia
Teva's generic EpiPen approved in the U.S., with perfect timing - MarketWatch
Teva's Earnings and Outlook Miss Estimates. Currency Moves Are to Blame. | Barron's
Teva Pharmaceutical Stock Could Double | Barron's
Teva's Battered Stock Looks Extremely Cheap | Barron's
Is Teva A Falling Drug Company Or A Great Value Proposition (NYSE:TEVA) | Seeking Alpha
Teva Tries to Put an End to the Opioid Wars - WSJ
Teva stock drops on guidance, manufacturing problems - MarketWatch
Investors wary of Teva-Mylan merger - MarketWatch
Teva shares drop 3% after rival generic product approved and launched - MarketWatch
